| A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions: the SOS (Stenting of Saphenous Vein Grafts) trial ES Brilakis, C Lichtenwalter, JA de Lemos, M Roesle, O Obel, D Haagen, ... Journal of the American College of Cardiology 53 (11), 919-928, 2009 | 223 | 2009 |
| Changing trends in etiology-based annual mortality from chronic liver disease, from 2007 through 2016 D Kim, AA Li, C Gadiparthi, MA Khan, G Cholankeril, JS Glenn, A Ahmed Gastroenterology 155 (4), 1154-1163. e3, 2018 | 214 | 2018 |
| Changing trends in etiology‐based and ethnicity‐based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States D Kim, AA Li, BJ Perumpail, C Gadiparthi, W Kim, G Cholankeril, JS Glenn, ... Hepatology 69 (3), 1064-1074, 2019 | 183 | 2019 |
| SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19 A Tsatsakis, D Calina, L Falzone, D Petrakis, R Mitrut, V Siokas, M Pennisi, ... Food and Chemical Toxicology 146, 111769, 2020 | 177 | 2020 |
| Gastrointestinal bleeding in patients with severe SARS-CoV-2 C Gadiparthi, A Perisetti, H Sayana, B Tharian, S Inamdar, A Korman Official journal of the American College of Gastroenterology| ACG 115 (8 …, 2020 | 73 | 2020 |
| Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management R Chauhan, S Lingala, C Gadiparthi, N Lahiri, SR Mohanty, J Wu, ... World journal of hepatology 10 (3), 352, 2018 | 57 | 2018 |
| NAFLD epidemiology, emerging pharmacotherapy, liver transplantation implications and the trends in the United States C Gadiparthi, M Spatz, S Greenberg, U Iqbal, S Kanna, SK Satapathy, ... Journal of Clinical and Translational Hepatology 8 (2), 215, 2020 | 47 | 2020 |
| Non-alcoholic fatty liver disease: a review of anti-diabetic pharmacologic therapies HS Snyder, SA Sakaan, KL March, O Siddique, R Cholankeril, ... Journal of clinical and translational hepatology 6 (2), 168, 2018 | 38 | 2018 |
| Nonalcoholic fatty liver disease: epidemiology, liver transplantation trends and outcomes, and risk of recurrent disease in the graft A Liu, A Galoosian, D Kaswala, AA Li, C Gadiparthi, G Cholankeril, D Kim, ... Journal of Clinical and Translational Hepatology 6 (4), 420, 2018 | 34 | 2018 |
| Hyperglycemia, hypertriglyceridemia, and acute pancreatitis in COVID-19 infection: clinical implications C Gadiparthi, M Bassi, B Yegneswaran, S Ho, CS Pitchumoni Pancreas 49 (7), e62-e63, 2020 | 33 | 2020 |
| Gastrointestinal and hepatic disease in the inflammatory myopathies C Gadiparthi, A Hans, K Potts, MK Ismail Rheumatic Disease Clinics 44 (1), 113-129, 2018 | 32 | 2018 |
| Temporal trends associated with the rise in alcoholic liver disease-related liver transplantation in the United States G Cholankeril, C Gadiparthi, ER Yoo, BB Dennis, AA Li, M Hu, K Wong, ... Transplantation 103 (1), 131-139, 2019 | 30 | 2019 |
| Role of cholecystectomy after endoscopic sphincterotomy in the management of choledocholithiasis in high-risk patients: a systematic review and meta-analysis MA Khan, Z Khan, CR Tombazzi, C Gadiparthi, W Lee, CM Wilcox Journal of Clinical Gastroenterology 52 (7), 579-589, 2018 | 29 | 2018 |
| Mechanistic potential and therapeutic implications of cannabinoids in nonalcoholic fatty liver disease P Dibba, A Li, G Cholankeril, U Iqbal, C Gadiparthi, MA Khan, D Kim, ... Medicines 5 (2), 47, 2018 | 27 | 2018 |
| Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates C Gadiparthi, G Cholankeril, BJ Perumpail, ER Yoo, SK Satapathy, S Nair, ... World journal of gastroenterology 24 (3), 315, 2018 | 26 | 2018 |
| The role of cannabinoids in the setting of cirrhosis P Dibba, AA Li, G Cholankeril, U Iqbal, C Gadiparthi, MA Khan, D Kim, ... Medicines 5 (2), 52, 2018 | 24 | 2018 |
| Waitlist outcomes in liver transplant candidates with high MELD and severe hepatic encephalopathy C Gadiparthi, G Cholankeril, ER Yoo, M Hu, RJ Wong, A Ahmed Digestive Diseases and Sciences 63, 1647-1653, 2018 | 18 | 2018 |
| Opioid use disorder increases 30-day readmission risk in inflammatory bowel disease hospitalizations: a nationwide matched analysis P Charilaou, S Mohapatra, T Joshi, K Devani, C Gadiparthi, ... Journal of Crohn's and Colitis 14 (5), 636-645, 2020 | 17 | 2020 |
| Pre-operative delta-MELD is an independent predictor of higher mortality following liver transplantation G Cholankeril, AA Li, BB Dennis, C Gadiparthi, D Kim, AE Toll, ... Scientific Reports 9 (1), 8312, 2019 | 14 | 2019 |
| Opioid use disorder in admissions for acute exacerbations of chronic pancreatitis and 30-day readmission risk: a nationwide matched analysis P Charilaou, S Mohapatra, T Joshi, K Devani, C Gadiparthi, ... Pancreatology 20 (1), 35-43, 2020 | 13 | 2020 |
George CholankerilBaylor College of Medicinestanford.edu üzerinde doğrulanmış e-posta adresine sahip
